-
09.12.2024 | A global emergency: Tackling antimicrobial resistance
POLITICO | Microbes are becoming increasingly resistant to drugs, reversing medical gains and risking minor infections becoming deadly. We explore some of these threats as global leaders thrash out a United Nations text that has the chance to deliver ambitious pledges to tackle antimicrobial resistance.
-
09.12.2024 | These are the most deadly pathogens — so why aren’t drug companies targeting them?
POLITICO | Antibiotics are among the greatest success stories in the history of medicine. They have saved millions of lives by turning once-deadly diseases into curable conditions. But the golden era of antibiotics has come to an end.
-
09.12.2024 | A global drug-resistance crisis demands a global response
POLITICO | Resistance to antimicrobials is growing. Urgent action and global collaboration are needed to save lives. Could UNGA be a turning point?
-
09.10.2024 | Study: ‘Systemic weaknesses’ contribute to multidrug-resistant surgical infections in poorer nations
CIDRAP | Data from hospitals in seven low- and middle-income countries (LMICs) show high levels of multidrug resistance (MDR) in surgical-site infections (SSIs), limited microbiologic testing capacity, and frequently ineffective prophylactic (preventive) antibiotics, researchers reported late last week in The Lancet Global Health.
-
09.06.2024 | CDC’s role in antimicrobial resistance
CONTAGION LIVE | At this week’s World AMR Congress, Benjamin Park, MD, senior advisor for Global Programs, Division of Healthcare Quality Promotion, CDC’s National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), participated on a panel, titled, The Role of ID Surveillance to Reduce AMR.
-
09.05.2024 | Study suggests unnecessary antibiotics contribute to greenhouse gas emissions
CIDRAP | A new study by researchers at the University of Utah School of Medicine highlights the environmental impact of unnecessary antibiotic prescribing.
-
09.04.2024 | WHO issues global guidance to limit antibiotic pollution from manufacturing
CIDRAP | The World Health Organization (WHO) has released new guidance on what it calls an "important but neglected challenge" in efforts to tackle antimicrobial resistance (AMR).The guidance, released yesterday, provides targets aimed at limiting the emergence and spread of AMR from antibiotic manufacturing plants, which are a documented source of antibiotic pollution but remain largely unregulated.
-
09.03.2024 | New global guidance aims to curb antibiotic pollution from manufacturing
THE WORLD HEALTH ORGANIZATION | The World Health Organization (WHO) has published its first-ever guidance on antibiotic pollution from manufacturing. The new guidance on wastewater and solid waste management for antibiotic manufacturing sheds light on this important but neglected challenge ahead of the United Nations General Assembly (UNGA) High-Level Meeting on antimicrobial resistance (AMR) taking place on 26 September 2024.
-
09.03.2024 | New WHO guidance takes aim at ‘antibiotic pollution’ from manufacturing labs
UNITED NATIONS | The directive covers wastewater and solid waste management for manufacturing of antibiotics, and comes ahead of a High-Level Meeting on antimicrobial resistance (AMR) that will be held during the UN General Assembly later this month in New York.
-
09.03.2024 | More countries are addressing AMR, but many reluctant to commit to specific cut to animal antibiotic use
HEALTH POLICY WATCH | While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR.
-
09.02.2024 | Explained: the history of progress in tackling antimicrobial resistance
WELLCOME | This century has seen greater political interest in antimicrobial resistance and increased efforts to monitor, understand and treat drug-resistant infections. Is enough being done to tackle a growing global health crisis?
-
08.26.2024 | Efforts to reduce antimicrobial resistance in low-resource nations are lagging, survey suggests
CIDRAP | A survey of public health experts from low- and middle-income countries (LMICs) highlights significant gaps in implementation and enforcement of policies aimed at mitigating antimicrobial resistance (AMR), researchers reported late last week in BMC Public Health.
-
08.21.2024 | What happens when the last AMR researcher turns off the lights in the lab?
INFECTIOUS DISEASE SPECIAL EDITION | Much of modern medicine is possible because of antibiotics. Orthopedic surgeries, caesarean deliveries, and heart and kidney transplants are made safer by antibiotics.
-
08.21.2024 | Deep-sequencing technique provides more complete picture of resistant bacteria in hospitals
CIDRAP | A new genomic sequencing technique could help hospitals better track and control the spread of multiple drug-resistant pathogens, researchers reported yesterday in The Lancet Microbe.
-
08.19.2024 | Report highlights challenges of tackling antimicrobial resistance in Africa
CIDRAP | Amid a burgeoning mpox crisis, African health officials are drawing attention to the growing burden of antimicrobial resistance (AMR) on the continent and have laid out a roadmap for addressing the problem.
-
08.15.2024 | Antimicrobial resistance is a greater threat than HIV-AIDS, TB and malaria, says new report
AFRICA CDC | The likelihood of falling ill or dying from diseases that resist treatment has escalated in Africa, with children and other vulnerable groups being most at risk, according to a new report by the Africa Centres for Disease Control and Prevention (Africa CDC).
-
08.14.2024 | Study finds significant pre-COVID declines in antibiotic-resistant infections at VA hospitals
CIDRAP | An analysis of 15 years' of data from the Veterans Affairs (VA) Healthcare System found significant reductions in several antibiotic-resistant healthcare-associated infections (HAIs) prior to the COVID-19 pandemic, US researchers reported yesterday in The Lancet Infectious Diseases.
-
08.14.2024 | As a cancer care expert, my fears over my own diagnosis run deeper than just curing the disease
THE GUARDIAN | My treatment for aggressive lymphoma has been successful but severely weakened my immune system. Like many others, antimicrobial resistance could kill me, even if the cancer itself is survivable.
-
08.13.2024 | Five ways science is tackling the antibiotic resistance crisis
NATURE | Humans are locked in an arms race with microbes, but scientists are pursuing diverse approaches to keep one step ahead or slow down the competition.
-
08.13.2024 | Putting a face on the ‘invisible threat’ of antimicrobial resistance
CIDRAP | While it's a different type of crisis than the COVID-19 pandemic, antimicrobial resistance (AMR) is one of the most significant public health threats facing the world. The most widely cited study, published in The Lancet Infectious Diseases, estimates that drug-resistant infections contributed to nearly 5 million deaths globally in 2019 and were directly responsible for 1.27 million.
-
08.12.2024 | Study links inadequate therapy, delayed newer antibiotics to worse outcomes
CIDRAP | A retrospective analysis of data on US hospital patients with infections caused by Enterobacterales and Pseudomonas aeruginosa found that inadequate empiric therapy (IET) and delayed use of newer antibiotics was associated with significantly worse outcomes, researchers reported late last week in BMC Infectious Diseases.
-
08.11.2024 | Fighting the looming ‘silent pandemic’
NEOS KOSMOS | When Jane Fletcher went into hospital for routine surgery she never expected to come out with a superbug and a front-row seat to the ‘silent pandemic’.
-
08.09.2024 | What is antimicrobial resistance – and why is it a global health threat?
BUREAU OF INVESTIGATIVE JOURNALISM | Drug-resistant infections are a growing threat worldwide. Here’s the science behind it – and how we can tackle the issue.
-
08.08.2024 | ‘It’s at the scale of a pandemic’: superbug emergency puts babies on the frontline
BUREAU OF INVESTIGATIVE JOURNALISM | In Nigeria and Ethiopia, neonatal sepsis poses a major threat to newborns. And as antibiotic resistance grows, a crisis is mounting.
-
08.08.2024 | ‘It’s happening on the scale of a pandemic’: the drug-resistant infections killing African babies
THE GUARDIAN | Illnesses that would once have been easily managed are no longer responding to antibiotics, and the world’s poorest regions are being hit hardest.
-
08.07.2024 | WHO calls for coordinated effort to boost antibiotic development
CIDRAP | In a policy brief published earlier this week, the World Health Organization (WHO) called for global coordination on policies to strengthen the antibacterial pipeline.
-
08.07.2024 | ‘I lost my son to sepsis’: the fightback against the spread of superbugs
THE GUARDIAN | Global leaders are preparing for a summit on antimicrobial resistance, which kills more than a million people a year, and those affected want to be seen as more than numbers.
-
08.07.2024 | How discharged patients can carry superbugs home
AXIOS | Discharged hospital patients can carry superbugs home and infect relatives or caregivers, even if they weren't sickened by the bacteria, per a study in Infection Control & Hospital Epidemiology.
-
08.05.2024 | Babies in Nigeria are being born with antibiotic resistant bacteria
THE CONVERSATION | Sepsis occurs when one’s immune system has an extreme response to an infection. It’s a life-threatening condition: globally, it accounts for about 11 million deaths – 20% of all deaths per year. And it doesn’t just affect adults.
-
08.03.2024 | Antimicrobial resistance on the rise due to wars in Ukraine and Gaza
FORBES | Increasingly, multidrug-resistant bacteria circulate in war zones in Ukraine and Gaza. These so-called superbugs often don’t respond to antibiotics. In turn, infections are becoming more difficult to treat which can lead to severe illness or death, among both military personnel and civilians.
-
08.01.2024 | WHO warns of moderate-risk level for drug-resistant K. pneumoniae
BECKER'S HOSPITAL REVIEW | A strain of bacteria that causes severe and sometimes drug-resistant infections has been detected in all six World Health Organization regions, the group reported July 31.
-
08.01.2024 | WHO warns of increase in hypervirulent, multidrug-resistant Klebsiella strains
CIDRAP | The World Health Organization (WHO) is warning countries about increasing reports of hypervirulent and multidrug-resistant Klebsiella pneumoniae (hvKp).
-
07.31.2024 | Antimicrobial resistance, hypervirulent Klebsiella pneumoniae – global situation
THE WORLD HEALTH ORGANIZATION | K. pneumoniae strains that can cause severe infections in healthy individuals and have been identified with increasing frequency in recent years are considered hypervirulent compared to classical strains because of their ability to infect both healthy and immunocompromised individuals and because of their increased tendency to produce invasive infections.
-
07.30.2024 | CDC study highlights COVID’s impact on infection control, multidrug-resistant pathogens in hospitals
CIDRAP | A new study by researchers with the Centers for Disease Control and Prevention (CDC) illustrates the impact that the COVID-19 pandemic had on infection control (IC) practices in US hospitals, even in parts of the country that experienced lower SARS-CoV-2 transmission.
-
07.30.2024 | Heteroresistance: An insidious form of antibiotic resistance
AMERICAN SOCIETY FOR MICROBIOLOGY | Are all cells in a population of bacteria identical? When it comes to antibiotic resistance, the answer is a clinically unfortunate “no.”
-
07.29.2024 | You asked, we answered: What is antibiotic resistance?
NEBRASKA MEDICINE | I’ve heard about “superbugs” that can’t be stopped by antibiotics. But what does it mean when bacteria are resistant to antibiotics, and how does this happen?
-
07.29.2024 | Review and meta-analysis finds high rates of antibiotic resistance in hypervirulent Klebsiella
CIDRAP | A systematic review and meta-analysis found high rates of resistance to older and newer antibiotics in strains of hypervirulent Klebsiella pneumoniae (hvKp), researchers reported last week in the Journal of Global Antimicrobial Resistance.
-
07.26.2024 | Hospital-acquired infections are rising – here’s how to protect yourself in health care settings
THE CONVERSATION | A new study from the National Institutes of Health shows a jump in both hospital-acquired infections and resistance to the antibiotics used to treat them. Dr. Nasia Safdar, a professor of infectious medicine at the University of Wisconsin-Madison, discusses why infection rates have gone up and how you can protect yourself as a hospital patient or visiting family member.
-
07.26.2024 | Op-ed, The Epoch Times: We are losing antibiotics—and we can’t afford to
HOUSE BUDGET COMMITTEE | Local health care systems across the country are at risk of no longer working as we once knew them. The problem is doctors and nurses are running out of antibiotics to treat their patients—and the costs of inaction threaten the health and financial well-being of every American.
-
07.23.2024 | Genomic surveillance could be a step change in tackling antimicrobial resistance
UNIVERSITY OF BIRMINGHAM | 100 years ago, we did not have antibiotics.The reality is that if antimicrobial resistance is left to continue at its current pace, we may be running out of antibiotics before the end of this century.
-
07.22.2024 | A growing threat that needs public attention
WAMC NORTHEAST PUBLIC RADIO | Due to the overuse and misuse of antibiotics in humans and animals, many strains of bacteria have evolved resistance to medically important antibiotics, meaning they are not killed by the drugs. Instead, they survive, multiply, and spread.
-
07.21.2024 | Could a conflict-borne superbug bring on our next pandemic?
ROLLING STONE | New breeds of drug-resistant bacteria are proliferating in war-torn parts of the globe — and spreading from the battlefield to hospitals and across borders.
-
07.17.2024 | ESCMID releases guidance on antimicrobial stewardship in emergency departments
CIDRAP | The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) today published guidelines for antimicrobial stewardship in emergency departments (EDs), which are endorsed by the European Association of Hospital Pharmacists. The guidelines appear in Clinical Microbiology and Infection.
-
07.17.2024 | SHEA calls for more CDC funds after data show 20% hike in resistant hospital infections
CIDRAP | A fact sheet published by the US Centers for Disease Control and Prevention (CDC) yesterday highlights a 20% rise in hospital-onset infections caused by antimicrobial-resistant pathogens and a fivefold increase in Candida auris infections during the COVID-19 pandemic compared with 2019.
-
07.16.2024 | Antimicrobial resistance threats in the United States, 2021-2022
CENTERS FOR DISEASE CONTROL AND PREVENTION | CDC used new data to update the United States burden of seven antimicrobial-resistant pathogens typically found in healthcare settings. The new data describe the burden in the two following years, 2021 and 2022, and compares against 2019 data.
-
07.14.2024 | ‘My baby died in my arms’: A mother on the dangers of AMR
THE JOURNAL | The world is facing a health crisis which is as serious as the Covid-19 pandemic and could cause millions of premature deaths, but we’re not doing enough to mitigate the risks, experts have warned.
-
07.13.2024 | The superbugs lurking in seas and rivers
BBC | Antimicrobial resistance (AMR) develops when the genetic codes of pathogens, including bacteria present in sewage, mutate to resist medicines designed to control infections. Infections caused by the resulting drug-resistant pathogens, sometimes referred to as "superbugs", are estimated to be directly linked to 1.27 million deaths each year.
-
07.12.2024 | Climate change could return us to the pre-antibiotic era
SALON | We are in a race with ever-evolving bacteria — and we are losing. Climate change is making the battle much harder.
-
07.11.2024 | Resisting antibiotic-resistant bacteria
OTAGO DAILY TIMES | A surprise discovery of microscopic proportions at the University of Otago may have massive potential when it comes to solving the world’s growing resistance to antibiotics. Antibiotic resistance is when bacteria change to resist antibiotics, making certain bacterial infections difficult to treat.
-
07.10.2024 | Why is antimicrobial resistance not getting much attention from biopharma?
BIOSPACE | The creation of antibiotics stands as one of the greatest medical breakthroughs in history, saving hundreds of millions of lives, and now halting the rise of AMR has emerged as a global health imperative. The World Health Organization (WHO) has declared that AMR is one of the top global public health and development threats, with nearly 5 million associated deaths per year.
-
07.10.2024 | GRAM, IDDO announce AMR data repository to strengthen research and improve access
CENTRE FOR TROPICAL MEDICINE AND GLOBAL HEALTH | Seeking to strengthen research on antimicrobial resistance (AMR) worldwide, the GRAM Project has joined with the Infectious Diseases Data Observatory (IDDO) to create an Oxford-based repository for AMR data, with the first curated dataset now available.
-
07.09.2024 | 70% of antibiotics used not working on patients: Expert
TIMES OF INDIA | Noted intensivists from across the country recently gathered in the city to speak at an international symposium on the increasing need for awareness of antimicrobial resistance (AMR).
-
07.08.2024 | AI able to identify drug-resistant typhoid-like infection from microscopy images in matter of hours
UNIVERSITY OF CAMBRIDGE | Artificial intelligence (AI) could be used to identify drug resistant infections, significantly reducing the time taken for a correct diagnosis, Cambridge researchers have shown. The team showed that an algorithm could be trained to identify drug-resistant bacteria correctly from microscopy images alone.
-
07.08.2024 | Impacts of antimicrobial resistance on cancer care
CENTERS FOR DISEASE CONTROL AND PREVENTION | In the eighth installment of CDC's AMR Exchange webinar series, experts discussed the intersection of antimicrobial resistance and cancer care and the importance of preventing infections in people receiving treatment for cancer.
-
07.08.2024 | Superbug that now kills 300,000 people a year evolved rapidly from common bacteria
THE INDEPENDENT | A deadly superbug that causes about 300,000 deaths a year evolved from being a common environmental bacterium and spread rapidly in just over two centuries, according to a new study that could help improve our understanding of immunity against invading bacteria.
-
07.05.2024 | Tackling antimicrobial resistance in agribusiness and environment
THE UNIVERSITY OF QUEENSLAND | A new training Centre led by The University of Queensland and headquartered at IMB is partnering with industry to tackle the global crisis of antimicrobial-resistant infections, which affect humans, animals and the environment.
-
07.03.2024 | PACCARB recommendations for global action against antimicrobial resistance
INFECTIOUS DISEASE ADVISOR | Members of the 25th Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) held a public meeting from May 21 to 22, 2024 to vote on recommendations to reduce the global threat of antimicrobial resistance (AMR).
-
07.01.2024 | WHO launches effort to boost global diagnostic capacity
CIDRAP | The World Health Organization (WHO) last week launched an effort to strengthen global diagnostic capacity and support access to safe, affordable, and quality-assured diagnostics.
-
07.01.2024 | Degradation of cell wall key in the spread of resistance
UMEÅ UNIVERSITY | A study at Umeå University, Sweden, provides new clues in the understanding of how antibiotic resistance spreads. The study shows how an enzyme breaks down the bacteria's protective outer layer, the cell wall, and thus facilitates the transfer of genes for resistance to antibiotics.
-
06.25.2024 | Building evidence for the use of bacteriophages against antimicrobial resistance
THE WORLD HEALTH ORGANIZATION | “My father felt powerless, like life was flowing out of him,” explains his daughter, Lies. At the age of 84, after Pim van Vliet underwent a surgery, he began suffering from a chronic urinary tract infection caused by a multi-drug resistant bacterium, Klebsiella pneumoniae.
-
06.20.2024 | Antimicrobial resistance: Why the next government needs to prepare for ‘the coming plague’
KING'S COLLEGE LONDON | Could antimicrobial resistance (AMR) be the incoming government’s next major challenge? AMR is a growing global threat, responsible for one in eight global deaths a year – estimated to kill 50 million people per year by 2050.
-
06.14.2024 | WHO releases report on state of development of antibacterials
THE WORLD HEALTH ORGANIZATION | The World Health Organization (WHO) today released its latest report on antibacterial agents, including antibiotics, in clinical and preclinical development worldwide. Although the number of antibacterial agents in the clinical pipeline increased from 80 in 2021 to 97 in 2023, there is a pressing need for new, innovative agents for serious infections and to replace those becoming ineffective due to widespread use.
-
06.06.2024 | Drug-resistant infections more likely to strike women, says WHO
NATURE | Women might be more likely to develop drug-resistant infections than men — an under-recognized aspect of the growing threat of antimicrobial resistance, according to a global review led by the World Health Organization (WHO). The report finds that more than 70% of countries do not recognize gender inequalities in national plans to tackle drug-resistant infections.
-
05.29.2024 | How the pandemic gave power to superbugs
NPR | Antibiotics cannot cure COVID. They don’t help a bit. And yet, new data shows that, during the pandemic, COVID patients were given antibiotics – a lot of antibiotics.
-
05.23.2024 | The Lancet Series on antimicrobial resistance: The need for sustainable access to effective antibiotics
THE LANCET | Access to effective antibiotics is essential to every health system in the world, however, antimicrobial resistance (AMR) threatens this backbone of modern medicine and is already leading to deaths and disease which would have once been prevented. This Series highlights that, although AMR can affect anyone throughout the life course, the very young, very old and severely ill are the ones suffering the most.
-
05.17.2024 | WHO updates list of drug-resistant bacteria most threatening to human health
THE WORLD HEALTH ORGANIZATION | The World Health Organization (WHO) today released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria grouped into critical, high and medium categories for prioritization. The list provides guidance on the development of new and necessary treatments to stop the spread of antimicrobial resistance (AMR).
-
05.13.2024 | Rise of drug-resistant superbugs could make Covid pandemic look ‘minor’, expert warns
THE GUARDIAN | Common infections will kill millions if drug resistance through misuse of antibiotics is not curbed, says England’s ex-chief medical officer
-
04.28.2024 | Climate change risks fuelling antibiotic-resistant ‘superbugs’
FINANCIAL TIMES | Antibiotic-resistant “superbugs” are among the greatest public health threats of our age — and researchers fear that climate change will make them still more dangerous.
-
04.24.2024 | FDA approves new treatment for uncomplicated urinary tract infections
U.S. FOOD AND DRUG ADMINISTRATION | Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus.
-
04.19.2024 | New antibiotics were underprescribed for hard-to-treat infections, study finds
STAT | Although U.S. regulators approved several new antibiotics for combating hard-to-treat bacteria during a recent five-year period, hospital doctors instead gave older, generic remedies to more than 40% of patients battling those stubborn pathogens, according to a new analysis.
-
03.14.2024 | There is a need for awareness about AMR in Indian hospitals: Experts
BHARAT | Admitting that the antimicrobial resistance (AMR) burden in India is among the highest in the world, the Indian Journal of Medical Research (IJMR) has said that healthcare-acquired infections (HAIs) and lack of awareness about it lead to AMR which is one of the top global public health and development threats.
-
03.13.2024 | New E. coli: One of the most problematic AMR bacteria in circulation
GASTROENTEROLOGY & ENDOSCOPY NEWS | A new strain of Escherichia coli has been discovered that is both highly virulent and resistant to some antibiotics.
-
03.12.2024 | Study reveals ‘considerable farmer knowledge’ on aspects of antibiotics risk
PHYS ORG | A study published in CABI Agriculture and Bioscience has revealed "considerable farmer knowledge" on different aspects of antibiotics risks—including antimicrobial resistance—associated with their use on livestock in Kenya.
-
03.07.2024 | University leads thinking on new information systems to tackle AMR at a national level
UNIVERSITY OF LIVERPOOL | Researchers at the University of Liverpool have worked with partners to set out a vision for protecting the UK public against antimicrobial resistance (AMR).
-
03.02.2024 | Strengthening laboratory capacities to combat antimicrobial resistance in Sierra Leone
THE WORLD HEALTH ORGANIZATION | In the ongoing battle against the growing threat of antimicrobial resistant (AMR) pathogens, Sierra Leone's Ministry of Health, with support from the World Health Organization (WHO), has embarked on a series of crucial training initiatives. These efforts aimed to equip healthcare professionals especially laboratory officers with the necessary skills to identify bacterial agents and perform antibiotic susceptibility tests as part of activities to combat the threat of AMR effectively.
-
03.01.2024 | CSIRO-funded grant advances breakthrough therapeutics for frontline antibiotic rescue
DOHERTY INSTITUTE | University of Melbourne Dr Stephanie Neville, a molecular microbiologist at the Doherty Institute specialising in antibiotic resistance of bacterial pathogens, has been awarded a $500,000 CUREator grant by Brandon BioCatalyst, in the Minimising Antimicrobial Resistance Stream supported by CSIRO.
-
03.01.2024 | AMR Industry Alliance calls for ‘bold, coordinated’ action on antimicrobial resistance
CIDRAP | The AMR Industry Alliance this week issued a "call-to-action" in advance of the United Nations (UN) High-Level Meeting on AMR (antimicrobial resistance) in September.
-
02.28.2024 | Continued efforts needed to fight antimicrobial resistance (AMR) in humans and animals
EUROPEAN FOOD SAFETY AUTHORITY | Resistance of Salmonella and Campylobacter bacteria to commonly used antimicrobials continues to be observed frequently in humans and animals, according to a report issued today by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC).
-
02.28.2024 | Can we keep up with the resistance?
INFECTIOUS DISEASE SPECIAL EDITION | Antimicrobial resistance (AMR) is a leading cause of death worldwide. In 2019 alone, AMR directly resulted in about 1.27 million deaths, and played a role in almost 5 million deaths. Without intervention, that death toll is expected to rise to about 10 million deaths per year by 2050.
-
02.28.2024 | European AMR trends in humans, animals, foods for 2021–2022
FOOD SAFETY MAGAZINE | The European Food Safety Authority (EFSA) and the European Center for Disease Prevention and Control (ECDC) recently published a joint report on antimicrobial resistance (AMR) in zoonotic pathogens from humans, animals, and food in 2021–2022. EFSA and ECDC warn about repeatedly observed resistance to common antibiotics in Salmonella and Campylobacter.
-
02.28.2024 | Can non-profits beat antibiotic resistance and soaring drug costs?
NATURE | Effective, affordable antimicrobial drugs aren’t moneymakers, despite being desperately needed. Can non-profit organizations pick up the slack?
-
02.27.2024 | Global Leaders Group lays out steps to boost antibiotic development, access
CIDRAP | The Global Leaders Group (GLG) on Antimicrobial Resistance (AMR) last week issued a series of recommendations to address shortfalls in the antibiotic pipeline and boost access to new antibiotics and diagnostics.
-
02.23.2024 | New guidance document to bolster AMR surveillance in the Western Pacific
DOHERTY INSTITUTE | In the ongoing battle against the threat of antimicrobial resistance (AMR), the WHO Collaborating Centre for Antimicrobial Resistance at the Doherty Institute, in collaboration with the WHO Regional Office for the Western Pacific (WPRO), has taken a significant step forward by developing a guidance document regarding AMR surveillance.
-
02.22.2024 | Report suggests lower antibiotic use in Europe led to less antimicrobial resistance
CIDRAP | A multi-agency report ties a reduction in antimicrobial consumption (AMC) in Europe to a decrease in overall antimicrobial resistance (AMR) in people and farm animals from 2014 to 2021.
-
02.19.2024 | Antimicrobial resistance diagnostic markets transforming global healthcare with innovative technologies and trends 2023-2027
BUSINESS WIRE | The healthcare sector is on the cusp of a revolution with the latest advancements in diagnostic technologies geared towards combatting antimicrobial resistance (AMR). This new comprehensive research publication analyzes the burgeoning market and the potential these technologies hold in the fight against one of the most pressing healthcare challenges of our time.
-
02.19.2024 | Study highlights high rate of multidrug-resistant urinary tract infections in East Africa
CIDRAP | An analysis of urinary tract infection (UTI) isolates from East African countries found that roughly half were multidrug-resistant (MDR), researchers reported last week in JAC-Antimicrobial Resistance.
-
02.15.2024 | Could a single synthetic molecule outsmart a variety of drug-resistant bacteria?
LA TIMES | An estimated 2.8 million people in the U.S. contract infections each year from bacteria resistant to antibiotics, according to the U.S. Centers for Disease Control. More than 35,000 of them die.
-
02.12.2024 | WHO updates list of medically important antibiotics for use in human medicine
CIDRAP | The World Health Organization (WHO) last week updated its list of medically important antimicrobials for use in human medicine, adding new categories based on their importance in human medicine, antimicrobial resistance (AMR) risk, and the potential human health implications of non-human use.
-
02.08.2024 | Report warns of ‘brain drain’ from antibiotic research and development
CIDRAP | Two new reports this week from a coalition of industries working to combat antimicrobial resistance (AMR) highlight some of the progress that's been made, along with a critical problem that could undermine efforts to develop much-needed new antibiotics.
-
02.07.2024 | Guidance on establishing national and local AMR surveillance systems in the Western Pacific Region
THE WORLD HEALTH ORGANIZATION | Antimicrobial resistance (AMR) is impacting our health, economies and development. Up to 5.2 million people may die because of resistant bacterial infections across the Western Pacific Region from 2020-2030.
-
01.18.2024 | Trial supports switch to oral antibiotics in patients with low-risk Staph bloodstream infections
CIDRAP | The results of a randomized clinical trial show that early switch to oral antibiotic therapy was non-inferior to continuing intravenous (IV) therapy in patients with low-risk Staphylococcus aureus bloodstream infection, researchers reported yesterday in The Lancet Infectious Diseases.
Toggle navigation